|
MMAA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.790550E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.202800E-01 |
| Normal-vs-Stage2 |
8.344200E-01 |
| Normal-vs-Stage3 |
5.029700E-04 |
| Normal-vs-Stage4 |
2.971700E-04 |
| Stage1-vs-Stage2 |
8.601200E-01 |
| Stage1-vs-Stage3 |
2.14469999999523E-05 |
| Stage1-vs-Stage4 |
1.98625999999757E-05 |
| Stage2-vs-Stage3 |
4.834200E-02 |
| Stage2-vs-Stage4 |
2.677600E-02 |
| Stage3-vs-Stage4 |
5.920200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.002600E-01 |
| Normal-vs-AfricanAmerican |
4.830400E-02 |
| Normal-vs-Asian |
2.392600E-01 |
| Caucasian-vs-AfricanAmerican |
2.251200E-01 |
| Caucasian-vs-Asian |
1.531990E-01 |
| AfricanAmerican-vs-Asian |
2.797900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.026000E-02 |
| Normal-vs-Female |
3.792200E-01 |
| Male-vs-Female |
1.716670E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.671400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.326200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.513650E-02 |
| Normal-vs-Age(81-100Yrs) |
2.647000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.081200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.170000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.670200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.474500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.445400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.472000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.187000E-01 |
| Normal-vs-Grade 2 |
1.282430E-01 |
| Normal-vs-Grade 3 |
2.361600E-03 |
| Normal-vs-Grade 4 |
1.66690999999775E-05 |
| Grade 1-vs-Grade 2 |
9.998200E-01 |
| Grade 1-vs-Grade 3 |
5.608100E-02 |
| Grade 1-vs-Grade 4 |
5.517600E-03 |
| Grade 2-vs-Grade 3 |
2.02969999999469E-05 |
| Grade 2-vs-Grade 4 |
6.98869999649077E-08 |
| Grade 3-vs-Grade 4 |
2.346200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.091800E-02 |
| Normal-vs-ccB subtype |
3.704300E-03 |
| ccA subtype-vs-ccB subtype |
8.75210000028659E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.981200E-01 |
| Normal-vs-N1 |
3.906600E-01 |
| N0-vs-N1 |
5.297400E-01 |
|
|
